Opus Point Partners Management’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Opus Point Partners Management’s Portfolio LABU Stock Details LABU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$3.09M	Buy	4,993 +71	+1%	+$59K	5.58%	3
2019 Q2	$4.94M	Buy	4,922 +21	+0.4%	+$20.3K	7.31%	3
2019 Q1	$5.87M	Buy	4,901 +1,436	+41%	+$1.49M	7.95%	3
2018 Q4	$2.28M	Buy	+3,465	New	+$3.63M	5.01%	3
2017 Q4	–	Sell	-800	Closed	-$1.37M	–	65
2017 Q3	$1.37M	Hold	800	–	–	1.23%	29
2017 Q2	$1.01M	Buy	800 +364	+83%	+$367K	0.92%	36
2017 Q1	$416K	Sell	436 -279	-39%	-$249K	0.31%	44
2016 Q4	$448K	Sell	715 -17	-2%	-$12.8K	0.36%	39
2016 Q3	$714K	Hold	732	–	–	0.4%	35
2016 Q2	$413K	Buy	732 +133	+22%	+$83.3K	0.4%	35
2016 Q1	$329K	Buy	+599	New	+$379K	0.25%	50
2015 Q4	–	Sell	-186	Closed	-$241K	–	61
2015 Q3	$241K	Buy	+186	New	+$568K	0.13%	51

Other funds holding LABU

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

HJMC

Hellman Jordan Management Company Quincy, Massachusetts $58.9M AUM 18.56% 1-Year Est. Return

HIS

Harvest Investment Services Oakbrook Terrace, Illinois $547M AUM 64.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return

TCM

Traynor Capital Management Malvern, Pennsylvania $1.7B AUM 39.15% 1-Year Est. Return

EWA

Exencial Wealth Advisors Oklahoma City, Oklahoma $3.22B AUM 20.17% 1-Year Est. Return

Gainplan Bloomfield Hills, Michigan $254M AUM 25.62% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Opus Point Partners Management's LABU Position: Q3 2019 in Review

Opus Point Partners Management increased its Direxion Daily S&P Biotech Bull 3X ETF (LABU) stake by 1.4% in Q3 2019, buying an estimated $59K and bringing the position to 4,993 shares worth $3.09M. The position accounts for 5.58% of the portfolio, ranked #3.

Opus Point Partners Management first reported a position in LABU in Q3 2015 and has held it in 12 quarters since. The position peaked at $5.87M in Q1 2019. 21 funds tracked by Wall St. Rank hold LABU as of Q3 2019.

Opus Point Partners Management held 4,993 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $3.09M as of Q3 2019.
Opus Point Partners Management bought 71 Direxion Daily S&P Biotech Bull 3X ETF shares in Q3 2019, an estimated $59K.
Direxion Daily S&P Biotech Bull 3X ETF made up 5.58% of Opus Point Partners Management's portfolio in Q3 2019, its #3 holding.
Opus Point Partners Management first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q3 2015 and has held it in 12 quarters since.
Opus Point Partners Management's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $5.87M in Q1 2019.
21 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q3 2019.

Based on Opus Point Partners Management's 13F filing for Q3 2019, filed 14 Nov 2019.